Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis

Yuan Dai,Shuangshuang Shi,Hongda Liu,Hong Zhou,Wenqiu Ding,Chenyang Liu,Linling Jin,Weiping Xie,Hui Kong,Qun Zhang

DOI: https://doi.org/10.1038/s41419-023-06375-x

2024-01-06

Cell Death and Disease

Abstract:Emerging evidence indicates that protein activities regulated by receptor protein tyrosine phosphatases (RPTPs) are crucial for a variety of cellular processes, such as proliferation, apoptosis, and immunological response. Protein tyrosine phosphatase receptor type O (PTPRO), an RPTP, has been revealed as a putative suppressor in the development of particular tumors. However, the function and the underlying mechanisms of PTPRO in regulating of lung adenocarcinoma (LUAD) are not well understood. In this view, the present work investigated the role of PTPRO in LUAD. Analysis of 90 pairs of clinical LUAD specimens revealed significantly lower PTPRO levels in LUAD compared with adjacent non-tumor tissue, as well as a negative correlation of PTPRO expression with tumor size and TNM stage. Survival analyses demonstrated that PTPRO level can help stratify the prognosis of LUAD patients. Furthermore, PTPRO overexpression was found to suppress the progression of LUAD both in vitro and in vivo by inducing cell death via mitochondria-dependent apoptosis, downregulating protein expression of molecules (Bcl-2, Bax, caspase 3, cleaved-caspase 3/9, cleaved-PARP and Bid) essential in cell survival. Additionally, PTPRO decreased LUAD migration and invasion by regulating proteins involved in the epithelial-to-mesenchymal transition (E-cadherin, N-cadherin, and Snail). Moreover, PTPRO was shown to restrain JAK2/STAT3 signaling pathways. Expression of PTPRO was negatively correlated with p-JAK2, p-STAT3, Bcl-2, and Snail levels in LUAD tumor samples. Furthermore, the anti-tumor effect of PTPRO in LUAD was significant but compromised in STAT3-deficient cells. These data support the remarkable suppressive role of PTPRO in LUAD, which may represent a viable therapeutic target for LUAD patients.

cell biology

What problem does this paper attempt to address?

The paper primarily investigates the role of protein tyrosine phosphatase PTPRO in lung adenocarcinoma (LUAD) and its potential mechanisms.

### Research Background and Objectives

- **Research Background**: Receptor protein tyrosine phosphatases (RPTPs) regulated protein activity is crucial for various cellular processes, including proliferation, apoptosis, and immune responses. PTPRO, as an RPTP, has been revealed as a potential suppressor in the development of certain tumors, but its function and mechanism in lung adenocarcinoma remain unclear.
- **Research Objectives**: To explore the role of PTPRO in lung adenocarcinoma and its regulatory mechanisms, and to assess its potential as a therapeutic target.

### Main Findings

- **Expression Analysis**: Through the analysis of clinical samples, it was found that the level of PTPRO in lung adenocarcinoma tissues is significantly lower than in adjacent non-tumor tissues, and the expression level of PTPRO is negatively correlated with tumor size and TNM staging.
- **Prognostic Significance**: The level of PTPRO helps predict the prognosis of patients with lung adenocarcinoma, with low expression associated with poorer survival rates.
- **Functional Validation**:
- In vitro experiments showed that overexpression of PTPRO can inhibit the growth of lung adenocarcinoma cells by inducing mitochondrial-dependent apoptosis, downregulating molecules that promote cell survival (such as Bcl-2) and upregulating pro-apoptotic molecules (such as Bax, cleaved-caspase 3/9, etc.).
- In vivo experiments also demonstrated that overexpression of PTPRO can inhibit tumor growth and reduce the tumor volume and weight in a nude mouse model.
- PTPRO can also reduce the migration and invasion capabilities of lung adenocarcinoma cells by regulating epithelial-mesenchymal transition (EMT) related proteins (such as E-cadherin, N-cadherin, and Snail).
- **Signal Pathway Regulation**: PTPRO can also inhibit the JAK2/STAT3 signaling pathway, which may be one mechanism by which it suppresses tumor growth.

In summary, the paper reveals the tumor-suppressive role of PTPRO in lung adenocarcinoma and its potential mechanisms, indicating that PTPRO may be an effective target for the treatment of lung adenocarcinoma.